Analysis using datasets from the Gene Expression Omnibus revealed that EZH2 expression levels were significantly higher in relapsed MM (RMM) patients than in normal plasma cells (NPCs) or newly diagnosed MM (NMM) patients (Fig. 1G). The gene discussed is EZH2; the disease is Miyoshi myopathy.